BTG PLC (LSE:BTG) - Share price - Overview

Stock Report

BTG PLC BTG

Last Price
GBX670.50

Day Change
5.00|0.75%

As of 22/09/2017
17:02:39 BST | GBX
Minimum 15 Minutes Delay.

Last Close665.50p
Day Range661.00 - 671.00
Mkt Cap2.57Bil
52-Wk Range528.36 - 738.50
Yield %0.00
ISINGB0001001592
Volume393,437
P/E41.41
P/S4.52
P/CF34.74

Share Price

Total Returns 22/09/2017

 Chg (%)  
More ...
BTG PLC-0.74 
FTSE 100 TR GBP-0.82
 
Financials
201520162017
More ...
Income Statement
Turnover367.80447.50570.50
Operating Profit34.9056.5057.50
Net Profit33.6060.5033.60
Reported EPS9.0015.608.60
Balance Sheet
Current Assets207.60297.50342.30
Non Current Assets838.30851.30968.80
Total Assets1,045.901,148.801,311.10
Current Liabilities115.60125.00165.50
Total Liabilities287.30301.10331.20
Total Equity758.60847.70979.90
Cash Flow
Operating Cash Flow62.70101.8084.60
Net Change in Cash34.8065.709.20
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2018149.0929.4481.8422.610.28--
2019184.0033.9115.1819.631.29--

Regulatory News

DateSourceHeadline
More ...
20/09/2017|07:00RNSBTG PLC - Legal Ruling
04/09/2017|09:52RNSBTG PLC - Total Voting Rights
01/09/2017|13:59RNSBTG PLC - Director/PDMR Shareholding
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
01/09/2017Exercise of OptionDame Louise Makin498.672,16510,796.00
09/06/2017SaleDame Louise Makin649.0030,641198,860.00
09/06/2017Transfer inDame Louise Makin0.0065,0300.00
09/06/2017SaleRolf Soderstrom649.0022,624146,830.00

Company Profile

BTG PLC is engaged in business of healthcare focusing on Interventional Medicine therapies for cancer, severe emphysema, severe bloodclots and varicose veins, and Specialty Pharmaceuticals for acute care uses, and a licensing business.

Sector

Biotechnology

Market Position

158 of 1837 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE techMARK All Share ,FTSE All Share ,FTSE techMARK Focus

Outlook

(13/07/2017) "...the board's expectations and guidance for the full year is unchanged"

Next Event 14/11/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)21.0812.9416.05
Div Yld (E)0.004.054.18
PEG (E)0.520.730.90
ROCE26.02191.3613.73
Op Mrgn14.97-4.32-15.22
EPS Grwth40.2721.8819.70
Dividends
PreviousLatest
More ...
Record Date25/07/9717/07/98
Ex-Div21/07/9713/07/98
Paid08/08/9707/08/98
Amnt0.880.92

Broker Sentiment

Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanGarry Watts
Chief Executive OfficerDame Louise Makin
Chief Financial OfficerRolf Soderstrom
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.